American Cancer Society National Prostate Cancer Roundtable

Meet the inaugural Chair of the American Cancer Society NPCRT, Dr. William Oh, MD! Dr. Oh is a Clinical Professor of Medicine at The Tisch Cancer Institute and the Icahn School of Medicine at Mount Sinai where he cares for patients with genitourinary malignancies, including prostate, renal, bladder and testicular cancers. He was recently the inaugural Chief Medical Officer at the Prostate Cancer Foundation (PCF). Prior to that, he was the Chief Medical Officer at Sema4, a patient-centered health intelligence company. Dr. Oh brings his 25 years of experience as a medical oncologist to his role as Chair, with a keen focus on improving patient outcomes by leveraging the strengths of the ACS Roundtables.

Check out our recap of last week’s American Cancer Society National #ProstateCancer Roundtable launch here: ?? https://lnkd.in/gUrY-kNv ? Fueled by the momentum generated during this amazing event, we're excited to move forward and begin driving impact, together, to improve prostate cancer outcomes and survivorship, for all. ? We'd like to extend a sincere thank you to our sponsors, Pfizer, Johnson & Johnson, and Bayer. It's thanks to your support that we're able to bring organizations together across sectors to foster collaboration, generate bold new ideas, and advance national priorities to reverse the rising incidence of prostate cancer.

September is #ProstateCancerAwarenessMonth. More than 3 million men in the U.S. are living with this disease, and 299,000 will be diagnosed this year. These numbers are unacceptable—so this month is dedicated to educating men and families about prostate cancer and how it impacts lives. Please share this post with someone you love—because raising awareness is one of the most powerful ways to get ahead of this disease. Learn more at zerocancer.org/pcam.

Huge thanks to Pfizer for their generous support of our Roundtable!

We’ve had an incredible week in Washington, DC launching the American Cancer Society National #ProstateCancer Roundtable! Thank you to our leadership, sponsors, speakers, and attendees. Your passion will propel us forward as we map out a path to action around our priority areas: - Risk assessment and screening. - Initial treatment strategies and treatment around localized prostate cancer. - Addressing advanced prostate cancer with appropriate imaging, therapies, and supports. Stay tuned to learn more about our leaders and why they’re excited to meet this critical moment with the strength of sustained partnership.

What is the American Cancer Society National Prostate Cancer Roundtable (ACS NPCRT)? Chief Patient Officer Dr. Arif Kamal MD, MBA explains this passionate coalition of organizations and how they plan to take action to solve complex problems and enact positive change.

The American Cancer Society is proud to launch the ACS National Prostate Cancer Roundtable. Some barriers are too complex for any one organization to tackle alone. #ACSNPCRT is the newest of ACS’s seven mission-critical roundtables dedicated to catalyzing collective action across the cancer continuum. ACS NPCRT was established to address the alarming rise in prostate cancer diagnoses in the US, particularly among Black men, who face disproportionate rates of incidence and mortality. Rooted in the power of partnership, the ACS NPCRT unites a coalition of diverse organizations under a shared mission: improving prostate cancer outcomes across the nation. We’re grateful to convene our leadership in Washington, DC this week to strategize, collaborate, and celebrate the launch of this shared effort. Visit our website to learn more: www.npcrt.org